View the event
| Reference: | 5045 |
| Country: | Iraq |
| Multiple country event: | No |
| Region: | EMRO |
| City: | Erbil |
| Start date: | 15 June 2013 |
| End date: | 20 June 2013 |
| Estimated duration: | 5 days |
| Status: | Planned - Planifié |
| | (The exact date, expert and funding source of the mission is unconfirmed) |
|
| Title: | Evaluation and on site training for second line DST |
| Type: | Mission |
| Terms of Reference: | -Carry out an assessment of the smear microscopy laboratory network coverage and quality in Iraq
-Carry out an assessment of the culture and anti-TB drug susceptibility testing in Iraq
-Evaluate the quality control mechanisms in the laboratory network in general and in the NRL in particular
-Carry out an assessment of the human resources capacity in the NRL and lab network
-Carry out on site training for second line DST.
Type of expert: An english/arabic speaking expert from the supranational reference laboratory. |
| Training Opportunity: | No |
| Website: | |
| Purpose 1: | Laboratory strengthening |
| Purpose 2: | Global Fund grant implementation |
| Purpose 3: | |
| Other purpose: | |
|
| Entered by: | WHO/EMRO |
| Partner 1: | |
| Partner 2: | |
| Partner 3: | |
| Contact name: | Dr Amal Bassili, Dr M AbdelAziz |
| Contact email: | bassilia@emro.who.int |
| Other agencies: | |
|
| Funding needs: | No |
| Funding source: | NA |
| Other funding source: | |
| Available funding: | $ 0 |
| Funding gap: | $ 0 |
| Global Fund reference: | |
|
| Comments: | This TA will improve GF performance indicators in relation to PMDT: improved access to drug susceptibility testing of second line anti-TB drugs, improved treatment of MDR-TB and enhanced detection fo XDR-TB.
|
| |
There are no documents attached associated with this event. There are no experts (roster) associated with this event. There are no experts (non-roster) associated with this event.
Date Created: 18 March 2013
Entered By: EMRO
|
